Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A-M, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376:1407–18.

Article  PubMed  Google Scholar 

Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010. JAMA. 2015;313:37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A-M, Miftaraj M, et al. Range of risk factor levels. Circulation. 2017;135:1522–31.

Article  PubMed  PubMed Central  Google Scholar 

Rawshani A, Rawshani A, Sattar N, Franzén S, Mcguire DK, Eliasson B, et al. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2019;139:1900–12.

Article  PubMed  Google Scholar 

Bebu I, Braffett BH, Orchard TJ, Lorenzi GM, Lachin JM. Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT/EDIC study. Diabetes Care. 2019;42:1284–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, et al. Prediction of first cardiovascular disease event in type 1 diabetes mellitus. Circulation. 2016;133:1058–66.

Article  PubMed  Google Scholar 

McGurnaghan SJ, McKeigue PM, Read SH, Franzen S, Svensson A-M, Colombo M, et al. Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia. 2021;64:2001–11.

Article  PubMed  PubMed Central  Google Scholar 

Jansa M, Quirós C, Giménez M, Vidal M, Galindo M, Conget I. Psychometric analysis of the Spanish and Catalan versions of a questionnaire for hypoglycemia awareness. Med Clín Engl Ed. 2015;144:440–4.

de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and kidney disease: improving global outcomes (KDIGO). Diabetes Care. 2022;45:3075–90.

Article  PubMed  PubMed Central  Google Scholar 

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315–81.

Article  PubMed  PubMed Central  Google Scholar 

Amor AJ, Vinagre I, Valverde M, Pané A, Urquizu X, Meler E, et al. Preeclampsia is associated with increased preclinical carotid atherosclerosis in women with type 1 diabetes. J Clin Endocrinol Metab. 2020;105:85–95.

Article  Google Scholar 

Martínez-González MA, Buil-Cosiales P, Corella D, Bulló M, Fitó M, Vioque J, et al. Cohort profile: design and methods of the PREDIMED-Plus randomized trial. Int J Epidemiol. 2019;48:387–388o.

Article  PubMed  Google Scholar 

Schröder H, Zomeño MD, Martínez-González MA, Salas-Salvadó J, Corella D, Vioque J, et al. Validity of the energy-restricted Mediterranean diet adherence screener. Clin Nutr. 2021;40:4971–9.

Article  PubMed  Google Scholar 

Serés-Noriega T, Viñals C, Perea V, Mesa A, Boswell L, Mariaca K, et al. Adherence to an energy-restricted Mediterranean diet is associated with the presence and burden of carotid atherosclerosis in people with type 1 diabetes. Diabetes Metab Res Rev. 2024;40(3): e3783.

Article  PubMed  Google Scholar 

Baber U, Mehran R, Sartori S, Schoos MM, Sillesen H, Muntendam P, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the bioimage study. J Am Coll Cardiol. 2015;65:1065–74.

Article  PubMed  Google Scholar 

Vigili de Kreutzenberg S, Fadini GP, Guzzinati S, Mazzucato M, Volpi A, Coracina A, et al. Carotid plaque calcification predicts future cardiovascular events in type 2 diabetes. Diabetes Care. 2015;38:1937–44.

Article  CAS  PubMed  Google Scholar 

Polak JF, Pencina MJ, Pencina KM, O’Donnell CJ, Wolf PA, D’Agostino RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011;365:213–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Näslund U, Ng N, Lundgren A, Fhärm E, Grönlund C, Johansson H, et al. Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial. Lancet. 2019;393:133–42.

Article  PubMed  Google Scholar 

Bengtsson A, Norberg M, Ng N, Carlberg B, Grönlund C, Hultdin J, et al. The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: results from the VIPVIZA randomized clinical trial. Am J Prev Cardiol. 2021;7: 100199.

Article  PubMed  PubMed Central  Google Scholar 

Boswell L, Serés-Noriega T, Mesa A, Perea V, Pané A, Viñals C, et al. Carotid ultrasonography as a strategy to optimize cardiovascular risk management in type 1 diabetes: a cohort study. Acta Diabetol. 2022;59(12):1563–74.

Article  CAS  PubMed  Google Scholar 

Amor AJ, Ortega E, Perea V, Cofán M, Sala-Vila A, Nuñez I, et al. Relationship between total serum bilirubin levels and carotid and femoral atherosclerosis in familial dyslipidemia. Arterioscler Thromb Vasc Biol. 2017;37:2356–63.

Junyent M, Cofán M, Núñez I, Gilabert R, Zambón D, Ros E. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2006;26:1107–13.

Article  CAS  PubMed  Google Scholar 

Touboul P-J, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004–2006–2011). Cerebrovasc Dis. 2012;34:290–6.

Article  PubMed  Google Scholar 

Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44:4043–140.

Article  CAS  PubMed  Google Scholar 

ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, Das SR, et al. 10. Cardiovascular disease and risk management: standards of care in diabetes—2024. Diabetes Care. 2024;47:S179-218.

Article  Google Scholar 

Lithovius R, Groop P-H. The many faces of hypertension in individuals with type 1 diabetes. Diabetes Res Clin Pract. 2023;197: 110564.

Article  PubMed  Google Scholar 

Lithovius R, Gordin D, Forsblom C, Saraheimo M, Harjutsalo V, Groop P-H. Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes. Diabetologia. 2018;61:1935–45.

Article  PubMed  Google Scholar 

Gourgari E, Mete M, Dimatulac M, Cogen F, Brady T. Blood pressure during sleep is associated with arterial stiffness and urine microalbumin to creatinine ratio in youth with type 1 diabetes. J Diabetes Complic. 2020;34: 107678.

Article  Google Scholar 

Rodrigues TC, Canani LH, Viatroski RS, Hoffmann LH, Esteves JF, Gross JL. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract. 2010;87:240–5.

Article  PubMed  Google Scholar 

Mateo-Gavira I, Vílchez-López FJ, García-Palacios MV, Carral-San Laureano F, Jiménez-Carmona S, Aguilar-Diosdado M. Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complic. 2016;30:1326–32.

Article  Google Scholar 

Jorge da Silva Franco R, Antonio Vieira Filho J, Inomata Cardoso da Silva D, Cuadrado Martin L, Alves Silva B, Garcia Zanati Bazan S, et al. Non-dipping circadian pattern as a predictor of incipient nephropathy in normotensive normoalbuminuric type 1 diabetics. Chronobiol Int. 2023;40:1523–8.

Article  CAS  PubMed  Google Scholar 

Chiriacò M, Sacchetta L, Forotti G, Leonetti S, Nesti L, Taddei S, et al. Prognostic value of 24-hour ambulatory blood pressure patterns in diabetes: a 21-year longitudinal study. Diabetes Obes Metab. 2022;24:2127–37.

Article  PubMed  PubMed Central  Google Scholar 

Hjortkjær HØ, Persson F, Theilade S, Winther SA, Tofte N, Ahluwalia TS, et al. Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes. J Diabetes Complic. 2022;36: 108270.

Article  Google Scholar 

Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension. J Hypertens. 2023;41:1874–2071.